Ally Bridge Group
Ally Bridge Group is a global healthcare investment management firm focused on high-impact life science innovation. Founded in 2013 by Frank Yu, the firm manages assets from offices in New York and Hong Kong. Ally Bridge Group has been the lead or co-lead on over $6 billion of transactions across healthcare subsectors. Their mission is to generate superior risk-adjusted returns for investors while addressing unmet medical needs, achieved by blending deep scientific and clinical research with proven M&A and capital markets expertise. They invest across the global healthcare industry through private equity and public equity strategies.
Ally Bridge Group
430 Park Avenue, 12th Floor, New York, New York 10022
Portfolio
Aims to develop next-generation genetic medicines using machine learning/AI.
#Biotechnology
Combines AI and machine learning with science to discover effective medicines.
#Drug Discovery
Develops a portable EEG headband for rapid diagnosis of neurological conditions.
#Medical Device
Uses electronic health records to ensure patient access to clinical research.
#Health Research
Key People
Founder, Chief Executive Officer, Chief Investment Officer
Chief Financial Officer, Public Equity
Executive Coordinator
Executive Coordinator
Finance Manager, Private Equity
Head of Operations, Public Equity